Cargando…
Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection
Two mRNA vaccines (BNT162b2 and mRNA-1273) against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) are globally authorized as a two-dose regimen. Understanding the magnitude and duration of protective immune responses is vital to curbing the pandemic. We enrolled 461 high-risk health se...
Autores principales: | Gray, Ashley N., Martin-Blais, Rachel, Tobin, Nicole H., Wang, Yan, Brooker, Sarah L., Li, Fan, Gadoth, Adva, Elliott, Julie, Faure-Kumar, Emmanuelle, Halbrook, Megan, Hofmann, Christian, Kashani, Saman, Kazan, Clayton, Yang, Otto O., Fulcher, Jennifer A., Grovit-Ferbas, Kathie, Rimoin, Anne W., Aldrovandi, Grace M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575273/ https://www.ncbi.nlm.nih.gov/pubmed/34748607 http://dx.doi.org/10.1371/journal.pone.0259703 |
Ejemplares similares
-
Dominant CD8(+) T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
por: Taus, Ellie, et al.
Publicado: (2022) -
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
por: Ibarrondo, F. Javier, et al.
Publicado: (2020) -
Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination
por: Taus, Ellie, et al.
Publicado: (2023) -
Vascular and Non-HLA autoantibody profiles in hospitalized patients with COVID-19
por: Lichtenstein, Brian, et al.
Publicado: (2023) -
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
por: Bowman, Kathryn A., et al.
Publicado: (2022)